High frequency of use of rofecoxib at greater than recommended doses: cause for concern.

Griffin MR, Stein CM, Graham DJ, Daugherty JR, Arbogast PG, Ray WA
Pharmacoepidemiol Drug Saf. 2004 13 (6): 339-43

PMID: 15170762 · DOI:10.1002/pds.879

MeSH Terms (20)

Aged Aged, 80 and over Anti-Inflammatory Agents, Non-Steroidal Arthritis Cross-Sectional Studies Drug Labeling Drug Prescriptions Drug Utilization Review Edema Female Humans Hypotension Lactones Male Medicaid Middle Aged Pharmacoepidemiology Sulfones Tennessee Time Factors

Connections (2)

This publication is referenced by other Labnodes entities: